Hemochromatosis primary prevention

Revision as of 18:35, 1 January 2019 by Shyam Patel (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Hemochromatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemochromatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemochromatosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemochromatosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemochromatosis primary prevention

CDC on Hemochromatosis primary prevention

Hemochromatosis primary prevention in the news

Blogs on Hemochromatosis primary prevention

Directions to Hospitals Treating Hemochromatosis

Risk calculators and risk factors for Hemochromatosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

There is no primary prevention of inherited hemochormatosis. However conditions causing secondary iron load can be avoided. Screening family members of a person diagnosed with hemochromatosis may detect the disease early so that treatment can be started before organ damage has occurred in other affected relatives.

Primary Prevention

There is no primary prevention of inherited hemochormatosis. However conditions causing secondary iron load can be avoided. Screening family members of a person diagnosed with hemochromatosis may detect the disease early so that treatment can be started before organ damage has occurred in other affected relatives.

Measurements Asymptomatic Symptomatic
Serum iron level (μg/dL) 150-280 180-300
Serum transferrin saturation 45-100 80-100
Serum ferritin level (μg/L) Men 150-1000 500-6000
Female 120-1000 500-6000
Hepatic iron concentration μg/g dry weight 2000-10,000 8000-30,000
Perls' Prussian blue stain 2+ to 4+ 3+, 4+
Hepatic iron index >1.9 >1.9

References

Template:WS Template:WH